Massachusetts Medicaid Wants to Stop Covering “High Cost” Drugs Bought Through 340B

(Editor’s note: The Medicare Payment Advisory Commission (MedPAC) tomorrow will consider a staff analysis of “whether the availability of 340B drug discounts creates incentives to choose more expensive products in some cases and the resulting impact on Medicare patients’ cost-share

Read More »

Breaking News

BREAKING: States Can Limit Providers’ Use of 340B Drugs for Medicaid Patients, CMS Says

BREAKING: States Can Limit Providers’ Use of 340B Drugs for Medicaid Patients, CMS Says

The Centers for Medicare & Medicaid Services released policy guidance yesterday outlining “best practices” states should consider for avoiding duplicate Medicaid rebates and 340B discounts

Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live